TelomEYE’s mission is to maintain and improve health by providing innovative scientific solutions.

Our scientific platform is based on preventing the cellular aging of the tissues and rejuvenating their functions via the telomere maintenance pathway (TMP). The importance of telomeres which are repetitive specialized DNA fragments on the ends of the chromosomes, was understood in the late 1980s. Further studies by Elisabeth H. Blackburn, Carol W. Greider and Jack W. Szostak were awarded Nobel Prize in Physiology or Medicine in 2009. *

TelomEYE is the first company to utilize telomere science in ophthalmology worldwide.

TelomEYE focuses on vision health, particularly age-related ophthalmological disorders such as presbyopia, cataracts, glaucoma and macular degeneration, which affect large populations and sometimes may lead to blindness. Presbyopia, for example, is one of the most common ophthalmologic disorders and reduces the quality of life of more than 2 billion people worldwide today.

*The Nobel Prize in Physiology or Medicine 2009. Nobel Prize Outreach AB 2022. Tue. 15 Nov 2022.